Two Dose Version of Johnson & Johnson Shot 94% Effective Against COVID-19, Study Finds
A two-dose version of Johnson & Johnson's coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday -- making a two-dose regimen of J&J's Janssen vaccine comparable to a two-dose regimen of Moderna's or Pfizer's. Awesome!
Photo Credit: Possessed Photography